Cargando…

Decreased Placental FPR2 in Early Pregnancies That Later Developed Small-For-Gestation Age: A Potential Role of FPR2 in the Regulation of Epithelial-Mesenchymal Transition

We reported earlier that an anti-inflammatory small peptide receptor-formyl peptide receptor-2 (FPR2) was significantly decreased in placentas from third trimester pregnancies complicated with fetal growth restriction (FGR), compared to placentas from uncomplicated control pregnancies, suggesting FP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murthi, Padma, Rajaraman, Gayathri, Erwich, Jan Jaap H.M., Dimitriadis, Evdokia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226808/ https://www.ncbi.nlm.nih.gov/pubmed/32290034 http://dx.doi.org/10.3390/cells9040921

Ejemplares similares

FPR Ligands
por: Liu, Ying, et al.
Publicado: (2013)

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
por: Zhuang, Youwen, et al.
Publicado: (2022)

Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages
por: Marutani, Takayuki, et al.
Publicado: (2021)

FPR2 Expression in Placental Extravillous Trophoblasts, and Its Relationship with Race, Delivery Mode, and Chorioamnionitis
por: Sweeney, Sarah, et al.
Publicado: (2022)

Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis
por: Ren, Tingting, et al.
Publicado: (2023)

N-Formylpeptides Induce Two Distinct Concentration Optima for Mouse Neutrophil Chemotaxis by Differential Interaction with Two N-Formylpeptide Receptor (Fpr) Subtypes: Molecular Characterization of Fpr2, a Second Mouse Neutrophil Fpr
por: Hartt, Jennifer K., et al.
Publicado: (1999)

The ambiguous role of FPR1 in immunity and inflammation
por: Vacchelli, Erika, et al.
Publicado: (2020)

FPR2: A Novel Promising Target for the Treatment of Influenza
por: Alessi, Marie-Christine, et al.
Publicado: (2017)

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
por: Petri, Marcelo H., et al.
Publicado: (2015)

Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis
por: Li, Anna, et al.
Publicado: (2020)

Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023)

Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015)

FPR1 is the plague receptor on host immune cells
por: Osei-Owusu, Patrick, et al.
Publicado: (2019)

Neutrophil Infiltration of the Colon Is Independent of the FPR1 yet FPR1 Deficient Mice Show Differential Susceptibilities to Acute Versus Chronic Induced Colitis
por: Farooq, Shukkur M., et al.
Publicado: (2012)

ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland
por: Wang, Ching-Shuen, et al.
Publicado: (2016)

Structural basis of FPR2 in recognition of Aβ(42) and neuroprotection by humanin
por: Zhu, Ya, et al.
Publicado: (2022)

FPR1 mediates the tumorigenicity of human cervical cancer cells
por: Cao, Guangming, et al.
Publicado: (2018)

Application of small molecule FPR1 antagonists in the treatment of cancers
por: Ahmet, Djevdet S., et al.
Publicado: (2020)

Role of formyl peptide receptor 2 (FPR2) in the normal brain and in neurological conditions
por: Ong, Wei-Yi, et al.
Publicado: (2019)

The Role of Placental Homeobox Genes in Human Fetal Growth Restriction
por: Murthi, Padma, et al.
Publicado: (2011)

A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2
por: Gabl, Michael, et al.
Publicado: (2014)

The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus
por: Rahman, Fryad, et al.
Publicado: (2018)

FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
por: Hou, Xi-Lu, et al.
Publicado: (2017)

Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
por: Wickstead, Edward S., et al.
Publicado: (2020)

Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction
por: Koenig, Andrew L., et al.
Publicado: (2021)

WKYMVm/FPR2 Alleviates Spinal Cord Injury by Attenuating the Inflammatory Response of Microglia
por: Zhang, Wenwu, et al.
Publicado: (2022)

Keratinocytes use FPR2 to detect Staphylococcus aureus and initiate antimicrobial skin defense
por: Lebtig, Marco, et al.
Publicado: (2023)

Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
por: Cattaneo, Fabio, et al.
Publicado: (2013)

The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
por: Snapkov, Igor, et al.
Publicado: (2016)

Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer
por: Chen, Chen, et al.
Publicado: (2021)

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
por: Petrazzuolo, Adriana, et al.
Publicado: (2020)

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
por: Le Naour, Julie, et al.
Publicado: (2023)

FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization
por: Xie, Xiaohui, et al.
Publicado: (2021)

The beneficial effects of commensal E. coli for colon epithelial cell recovery are related with Formyl peptide receptor 2 (Fpr2) in epithelial cells
por: Chen, Keqiang, et al.
Publicado: (2023)

Fpr2/CXCL1/2 Controls Rapid Neutrophil Infiltration to Inhibit Streptococcus agalactiae Infection
por: Sun, Zeyu, et al.
Publicado: (2021)

Correction: The beneficial effects of commensal E. coli for colon epithelial cell recovery are related with Formyl peptide receptor 2 (Fpr2) in epithelial cells
por: Chen, Keqiang, et al.
Publicado: (2023)

Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
por: Cai, Yongqing, et al.
Publicado: (2018)

Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing †
por: Gröper, Jieny, et al.
Publicado: (2020)

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1
por: Sztupinszki, Zsofia, et al.
Publicado: (2021)

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
por: Carbonnier, Vincent, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ek0innlqh4gp2833ornil21ns